Ozempic cuts heart-attack risk by nearly 25% in older patients, new study finds
Short excerpt below. Click through to read at the original source.
The wildly popular Ozempic drug cuts heart attack, stroke and death risk by nearly 25% in older patients, according to a new study published by Novo Nordisk and released on Thursday.